Table of contents

• Trial overview
• Who can participate
• What is being studied
• What outcomes are measured
• Trial phase and status
• Key patient terms

Trial overview

The available trial is a first-in-human study, which means it is the first time this approach is being tested in people.^[1] It is designed to study the safety and preliminary efficacy of expanded autologous urothelial cells bioprinted during orthotopic neobladder surgery.^[1]

The study is interventional, so the research team gives the study procedure as part of the trial instead of only observing patients.^[1] The planned enrollment is 6 patients.^[1]

Who can participate

The trial is for patients with muscle-invasive bladder cancer (MIBC) who are eligible for neobladder reconstruction after radical cystectomy.^[1] Radical cystectomy means surgery to remove the bladder.^[1]

This means the study is focused on a very specific group of people who are already planned for major bladder surgery and may receive a new bladder, called an orthotopic neobladder.^[1]

What is being studied

The trial is studying AUROCELL-TX, listed in the source as aUroCell-Tx, used with the InvivoLPrint-U bioprinter during neobladder surgery.^[1] A bioprinter is a device that places living cells in a planned shape or structure for medical use.^[1]

The study summary says the goal is to evaluate the safety of the expanded autologous urothelial cells and the bioprinter combination in the surgical setting.^[1] In simple terms, researchers want to see whether this approach can be used safely during surgery and whether there are early signs that it may help.^[1]

What outcomes are measured

The main outcomes focus on safety after surgery.^[1] These include the proportion of patients with a fatal event (death), neobladder rejection, and the need for revision surgery.^[1]

The trial also measures the proportion of patients who are free from the combined endpoint of death, neobladder rejection, and need for revision surgery.^[1] A composite endpoint is one result that combines several important events into a single measure.^[1]

Researchers will also record peri- and post-surgical complications and serious adverse events (SAEs).^[1] These are important because they show what problems happen during surgery and in the recovery period.^[1]

Trial phase and status

This is a Phase 1 trial.^[1] Phase 1 studies are early trials that mainly look at safety and how the study approach performs in a small number of people.^[1]

The study status is Authorised.^[1] That means the trial has been approved to move forward.^[1]

Key patient terms

Autologous means the cells come from the same person who will receive them.^[1] This is important because the trial is using the patient’s own urothelial cells.^[1]

Urothelial cells are cells that line the inside of the urinary tract, including the bladder.^[1] Orthotopic neobladder means a new bladder made during surgery and placed in the usual bladder position.^[1]

Revision surgery means another operation is needed to fix or adjust the first surgery result.^[1] Peri-surgical means around the time of surgery, and post-surgical means after surgery.^[1]

Table of Contents

• What is Octreotide Acetate?
• Conditions Treated with Octreotide Acetate
• How Octreotide Acetate Works
• How Octreotide Acetate is Administered
• Ongoing Research and Clinical Trials
• Potential Side Effects and Safety Considerations

What is Octreotide Acetate?

Octreotide Acetate is a medication that belongs to a class of drugs called somatostatin analogs. It is also known by other names such as Sandostatin, SMS995, and Siroctid ^[1][2][3]. This medication is designed to mimic the effects of somatostatin, a natural hormone in your body that regulates various functions, particularly in the digestive system and certain glands.

Conditions Treated with Octreotide Acetate

Octreotide Acetate is used to treat several medical conditions, including:

• Acromegaly: A hormonal disorder that results from the production of too much growth hormone, leading to abnormal growth of body tissues ^[1][4]
• Neuroendocrine Tumors (NETs): Rare tumors that can occur in various parts of the body, particularly in the digestive system or lungs ^[5]
• Carcinoid Syndrome: A group of symptoms associated with certain types of NETs ^[6]
• Pancreatic Fistula: A complication that can occur after pancreatic surgery ^[3]
• Diarrhea associated with certain medications: For example, diarrhea caused by mycophenolate mofetil, an immunosuppressant drug ^[7]

How Octreotide Acetate Works

Octreotide Acetate works by mimicking the action of somatostatin in the body. It helps to:

• Reduce the production of certain hormones, such as growth hormone and insulin-like growth factor 1 (IGF-1) in acromegaly patients ^[1]
• Slow down the growth of tumors in patients with neuroendocrine tumors ^[5]
• Control symptoms associated with carcinoid syndrome, such as flushing and diarrhea ^[6]
• Reduce pancreatic secretions, which can help in preventing or treating pancreatic fistulas ^[3]

How Octreotide Acetate is Administered

Octreotide Acetate can be administered in several ways:

• Short-acting injections: Given subcutaneously (under the skin) multiple times a day ^[5]
• Long-acting release (LAR) formulations: Given as intramuscular injections every 28 days ^[8]
• Implants: Subcutaneous implants that release the medication over an extended period ^[4]
• Experimental formulations: Such as Debio 4126, a 12-week prolonged-release formulation being studied in clinical trials ^[6]

Ongoing Research and Clinical Trials

Researchers are continuously studying Octreotide Acetate to understand its effects better and explore new potential uses. Some areas of ongoing research include:

• Its impact on the immune system in patients with neuroendocrine tumors ^[5]
• Long-term safety and efficacy in treating acromegaly ^[8]
• Comparison with other medications like somatostatin in preventing pancreatic fistulas after surgery ^[3]
• Its potential use in treating polycystic kidney disease ^[9]
• Its effectiveness in treating advanced liver cancer ^[10]

Potential Side Effects and Safety Considerations

Like all medications, Octreotide Acetate can cause side effects. Common side effects may include:

• Gastrointestinal symptoms such as diarrhea, nausea, or abdominal pain
• Injection site reactions
• Changes in blood sugar levels
• Gallbladder problems

It’s important to note that the safety and tolerability of Octreotide Acetate are continually being evaluated in clinical trials ^[6]. Your healthcare provider will monitor you closely while you’re on this medication and adjust the dosage as needed to minimize side effects while maximizing benefits.

Table of Contents

• What is Methadone?
• Uses of Methadone
• How Methadone is Administered
• Effects and Benefits
• Potential Side Effects
• Genetic Factors Affecting Methadone Metabolism
• Ongoing Research

What is Methadone?

Methadone hydrochloride, also known simply as methadone, is a powerful opioid medication. It’s similar to morphine in its pain-relieving properties but has some unique characteristics that make it useful for various medical purposes^[1]. Other names for methadone include Dolophine and Eptadone^[2][3].

Uses of Methadone

Methadone is primarily used for:

• Pain Management: It’s effective for treating moderate to severe pain, especially after surgery or in patients with chronic pain conditions^[1].
• Opioid Addiction Treatment: Methadone is used to help reduce withdrawal symptoms in people trying to quit other opioids^[4].

How Methadone is Administered

Methadone can be given in several ways:

• Intravenous (IV): Injected directly into a vein, often during surgery or immediately after for pain control^[1].
• Oral: Taken by mouth as a liquid or pill^[5].

The dosage of methadone can vary depending on the patient’s weight and the purpose of treatment. For example, in some studies, doses ranged from 0.1 mg/kg to 0.4 mg/kg of body weight^[6][2].

Effects and Benefits

Methadone has several potential benefits:

• Long-lasting pain relief: Unlike some other opioids, methadone can provide pain relief for an extended period, often up to 24-36 hours after a single dose^[1].
• Reduced opioid consumption: Some studies suggest that using methadone during surgery may lead to less need for other pain medications afterward^[1][6].
• Faster onset of action: Methadone starts working more quickly than some other opioids like morphine^[1].

Potential Side Effects

Like all medications, methadone can cause side effects. Some potential side effects include:

• Nausea and vomiting^[6]
• Constipation^[6]
• Drowsiness^[6]
• Respiratory depression: This means slowed breathing, which can be dangerous and may require an antidote in severe cases^[6].

It’s important to note that when used as prescribed under medical supervision, many of these side effects can be managed or minimized.

Genetic Factors Affecting Methadone Metabolism

Research has shown that genetic factors can influence how a person’s body processes methadone. Specifically, variations in a gene called CYP2B6 can affect how quickly the body breaks down methadone. This could impact how long the drug stays in the body and its effectiveness^[5].

Ongoing Research

Scientists are continually studying methadone to better understand its effects and find new ways to use it safely and effectively. Some areas of current research include:

• Use in specific surgeries: Studies are looking at how methadone might help with pain control after surgeries like spinal fusion or hip fracture repair^[2][6].
• Combination with other medications: Researchers are investigating whether combining methadone with other drugs like ketamine might provide better pain relief with fewer side effects^[4].
• Long-term effects: Studies are examining the impact of methadone use on long-term outcomes like quality of life and mobility after surgery^[6].

Table of Contents

• What is Suxamethonium Chloride Dihydrate?
• Medical Uses
• How is it Administered?
• Dosage Information
• Other Names for Suxamethonium
• Precautions and Considerations

What is Suxamethonium Chloride Dihydrate?

Suxamethonium Chloride Dihydrate is a medication used in medical procedures, particularly during surgeries. It belongs to a class of drugs known as neuromuscular blocking agents^[1]. This medication is also referred to as Suxamethonium or Succinylcholine.

Medical Uses

Suxamethonium is primarily used in anesthesia. Its main purpose is to cause short-term paralysis of the muscles, which is particularly useful during certain medical procedures^[1]. Some common scenarios where Suxamethonium might be used include:

• To facilitate endotracheal intubation (inserting a breathing tube)
• During short surgical procedures that require muscle relaxation
• In emergency situations where rapid muscle paralysis is needed

How is it Administered?

Suxamethonium Chloride Dihydrate is administered via intravenous injection or infusion. This means it’s given directly into a vein^[1]. The specific product mentioned in the clinical trial data is “SUXAMETHONIUM AGUETTANT 10 mg/mL, solution injectable en seringue préremplie,” which translates to “Suxamethonium Aguettant 10 mg/mL, solution for injection in a pre-filled syringe.”

Dosage Information

The dosage of Suxamethonium is carefully calculated by healthcare professionals based on various factors including the patient’s weight, age, and the specific medical procedure. According to the clinical trial information, the maximum daily dose is 1 mg/kg (milligram per kilogram of body weight)^[1]. It’s important to note that this medication should only be administered by trained medical personnel in a controlled setting.

Other Names for Suxamethonium

Suxamethonium Chloride Dihydrate is known by several other names, which include^[1]:

• Succinylcholine chloride dihydrate
• Succinylcholine dichloride dihydrate
• Suxamethonium dichloride dihydrate

Precautions and Considerations

While Suxamethonium is an effective and widely used medication in anesthesia, there are several important considerations:

• It should only be used under the supervision of trained anesthesiologists or other qualified healthcare professionals.
• The medication causes temporary muscle paralysis, including the muscles used for breathing. Therefore, patients receiving this medication will need assistance with breathing during its effects.
• It’s classified as an auxiliary medication in the clinical trial context, meaning it’s used to support the main treatment or procedure rather than being the primary focus of the study^[1].
• As with any medication, there can be potential side effects or contraindications. These should be discussed with your healthcare provider if you’re scheduled for a procedure where Suxamethonium might be used.

Remember, Suxamethonium Chloride Dihydrate is a specialized medication used in specific medical contexts. If you have any questions or concerns about its use in your medical care, always consult with your healthcare provider for personalized information and advice.

Table of Contents

• What is Soya Oil, Purified?
• Medical Uses
• How is it Administered?
• Dosage Information
• Precautions and Considerations

What is Soya Oil, Purified?

Soya Oil, Purified is a medical product derived from soybeans. It is also known as Purified Soya-Bean Oil.^[1] This substance is used in medical settings as part of a treatment called fat emulsion, which is a way to provide nutrition to patients who cannot eat normally.

Medical Uses

Soya Oil, Purified is primarily used in medical settings for nutritional support. It is a component of intravenous nutrition, also known as parenteral nutrition. This type of nutrition is used when a patient cannot eat by mouth or when the digestive system is not functioning properly.^[1]

Some specific situations where Soya Oil, Purified might be used include:

• After surgery, when a patient cannot eat normally
• In patients with certain digestive system disorders
• In critically ill patients who need additional nutritional support

How is it Administered?

Soya Oil, Purified is administered through intravenous infusion. This means it is given directly into the bloodstream through a vein.^[1] It is not a medication that you would take by mouth or apply to your skin.

The product used in medical settings is called INTRALIPIDE 20 POUR CENT, émulsion pour perfusion, which translates to “Intralipid 20 Percent, emulsion for infusion” in English. This is a sterile fat emulsion that contains purified soya oil along with other ingredients to make it safe for intravenous use.

Dosage Information

The dosage of Soya Oil, Purified is carefully calculated by healthcare professionals based on a patient’s individual needs. According to the information provided, the maximum daily dose is 3 milliliters per kilogram of body weight.^[1]

It’s important to note that this medication is typically administered in a hospital or clinical setting under close medical supervision. Patients do not typically administer this medication to themselves at home.

Precautions and Considerations

While Soya Oil, Purified is an important medical product, there are some considerations to keep in mind:

• Allergies: If you have a known allergy to soybeans or any other components of the emulsion, you should inform your healthcare provider.
• Other medical conditions: Your doctor will consider your overall health status and any other medical conditions you have when deciding whether to use this treatment.
• Monitoring: During the infusion, medical staff will monitor you closely for any adverse reactions.

It’s crucial to provide your healthcare team with a complete medical history and information about any allergies or sensitivities you may have. This will help ensure that the treatment is safe and appropriate for you.

Table of Contents

• What is Sodium Acetate Trihydrate?
• Medical Uses
• How is it Administered?
• Current Research
• Potential Side Effects
• Precautions and Considerations

What is Sodium Acetate Trihydrate?

Sodium acetate trihydrate is a medical compound used in various intravenous (IV) solutions and treatments. It is a salt form of acetic acid and sodium, combined with three water molecules. This substance plays a crucial role in maintaining the body’s pH balance and electrolyte levels.^[1]

Sodium acetate trihydrate is also known by several other names, including:

• Sodium acetate hydrate
• Sodium acetate trihydrate (E262)
• Sodium acetate, trihydrate

Medical Uses

Sodium acetate trihydrate is primarily used in medical settings as part of intravenous fluids. These fluids are designed to help maintain or restore proper fluid balance, electrolyte levels, and pH in the body. Some common medical uses include:

• Fluid replacement therapy
• Electrolyte imbalance correction
• pH balance regulation
• Nutritional support in patients unable to eat or drink normally

It is often found in combination with other electrolytes and nutrients in various IV solutions, such as Ringer’s acetate, Plasma-Lyte, and SmofKabiven.^[2]

How is it Administered?

Sodium acetate trihydrate is typically administered intravenously as part of a balanced electrolyte solution. The most common routes of administration include:

• Intravenous infusion: A slow, controlled delivery of the solution into a vein over a period of time
• Intravenous bolus injection: A faster administration of a smaller volume of the solution

The specific dosage and rate of administration depend on the patient’s individual needs, medical condition, and the particular solution being used. It’s important to note that these treatments are always administered by healthcare professionals in clinical settings.^[3]

Current Research

Several ongoing clinical trials are investigating the use of solutions containing sodium acetate trihydrate in various medical contexts:

• Cardiac arrest treatment: A study is examining the effects of hypertonic sodium lactate infusion, which may include sodium acetate trihydrate, on brain injury in comatose survivors of cardiac arrest.^[4]
• Fluid management in neurosurgery: Researchers are investigating the impact of goal-directed fluid management using solutions that may contain sodium acetate trihydrate on postoperative complications in neurosurgery patients.^[5]
• Pediatric spinal fusion surgery: A trial is comparing the effectiveness of different IV solutions, including those with sodium acetate trihydrate, in managing fluid balance and reducing blood loss during spinal fusion surgery in children with scoliosis.^[6]

These studies aim to optimize the use of IV fluids containing sodium acetate trihydrate and improve patient outcomes in various medical scenarios.

Potential Side Effects

While sodium acetate trihydrate is generally considered safe when used as directed, some potential side effects may occur. These can include:

• Fluid overload (if too much is administered)
• Electrolyte imbalances
• Allergic reactions (rare)
• Local irritation at the injection site

It’s important to note that these side effects are often related to the overall IV solution rather than sodium acetate trihydrate specifically. Healthcare providers carefully monitor patients receiving these treatments to minimize the risk of adverse effects.^[7]

Precautions and Considerations

While sodium acetate trihydrate is an important component in many IV solutions, certain precautions should be taken:

• Patients with kidney problems may need adjusted dosages or alternative treatments.
• Those with heart conditions should be monitored closely during administration.
• Pregnant and breastfeeding women should only receive these treatments when clearly necessary.
• Interactions with other medications should be considered and monitored by healthcare providers.

Always inform your healthcare provider about any medical conditions, allergies, or medications you are taking before receiving any IV treatments.^[8]

Table of Contents

• Trial overview
• Cancer-related thrombocytopenia studies
• Immune thrombocytopenia studies
• Cardiac surgery study
• Main endpoints used in the trials
• Who can participate

Trial overview

The trial data show several studies of Romiplostim in adults with low platelet counts. These studies are interventional, which means the research team gives a study treatment and measures the results. The listed studies are in Phase 2 or Phase 3, and they include completed, authorised, and ongoing/approved studies.^{[1][2][3][4][5]}

Across the trials, the main question is whether Romiplostim can help people keep platelet counts high enough to avoid treatment problems. In cancer studies, the goal is often to prevent chemotherapy delays or dose changes. In immune thrombocytopenia studies, the goal is to improve platelet response and reduce the need for more treatment.^[1][2][4][5]

Cancer-related thrombocytopenia studies

Two Phase 3 studies focus on chemotherapy-induced thrombocytopenia, which means low platelet counts caused by chemotherapy. One study enrolled adults with gastrointestinal, pancreatic, or colorectal cancer, and the other enrolled adults with non-small cell lung cancer, ovarian cancer, or breast cancer.^[1][5]

In both cancer studies, the main goal is to see whether Romiplostim helps patients receive chemotherapy on time and at full dose. The studies compare Romiplostim with placebo, which is an inactive treatment used for fair comparison. The primary outcome looks at whether chemotherapy had to be reduced, delayed, skipped, or stopped because platelet counts dropped below 100 x 10⁹/L.^[1][5]

These studies matter because chemotherapy schedules are important for cancer care. If platelet counts stay too low, treatment may need to change, and that can affect the planned cancer therapy. The trials are measuring whether Romiplostim can help avoid those changes.^[1][5]

Immune thrombocytopenia studies

Two studies focus on immune thrombocytopenia, a condition where the body attacks its own platelets. One Phase 3 study is in newly diagnosed primary immune thrombocytopenia and compares Romiplostim plus dexamethasone with dexamethasone alone.^[2]

The main outcome in that study is a sustained response off treatment, called 6mSROT-50. This means platelet counts stay at or above 50 x 10⁹/L for at least 6 months after treatment stops, without any ITP treatment or rescue treatment, and without major bleeding of WHO grade 2 or higher.^[2]

A second Phase 2 study, called T-MEM, looks at a more complex treatment plan for immune thrombocytopenia. It measures platelet counts at several visits and checks how many patients are in remission without needing therapy at later visits.^[4]

This means the research is not only asking whether platelet counts rise, but also whether people can stay well without ongoing treatment. That is important for patients who want a longer-lasting response rather than short-term control only.^[2][4]

Cardiac surgery study

One Phase 2 study looks at thrombocytopenic patients undergoing cardiac surgery. It tests Romiplostim before surgery and compares it with placebo or a sodium chloride solution used as a control treatment.^[3]

The main outcome is the lowest platelet count measured from the end of CEC to the 7th day after surgery. CEC means cardiopulmonary bypass, a machine used during some heart operations to keep blood moving while the heart is stopped.^[3]

This study is focused on how severe the platelet drop is after surgery. The trial is trying to find out whether preoperative Romiplostim can reduce the depth of thrombocytopenia after the operation.^[3]

Main endpoints used in the trials

The primary endpoint is the main result a trial measures to answer its research question. In these Romiplostim studies, the primary endpoints include platelet counts, bleeding-related outcomes, and whether chemotherapy can continue without dose changes.^{[1][2][3][4][5]}

• No thrombocytopenia-induced modification of chemotherapy means the patient can keep the planned chemotherapy schedule without dose reduction, delay, omission, or stopping treatment because of low platelets.^[1][5]

• 6mSROT-50 measures a lasting platelet response after treatment stops, showing whether the benefit continues for 6 months without other ITP treatment.^[2]

• Lowest platelet count after surgery shows how far the platelet level falls after cardiac surgery and whether the study treatment may limit that drop.^[3]

• Platelet count at follow-up visits is used in the T-MEM study to track response over time and remission without therapy.^[4]

These endpoints are practical and patient-focused. They show whether treatment helps people stay on their planned care path, avoid bleeding problems, or reach a stable response without ongoing medicine.^{[1][2][3][4][5]}

Who can participate

The listed studies include different patient groups, so eligibility depends on the condition being studied. The cancer trials include adult subjects with gastrointestinal, pancreatic, colorectal, non-small cell lung, ovarian, or breast cancer who have chemotherapy-induced thrombocytopenia.^[1][5]

The immune thrombocytopenia studies include people with newly diagnosed primary immune thrombocytopenia or immune thrombocytopenia more broadly. The cardiac surgery study includes thrombocytopenic patients who are scheduled for cardiac surgery.^[2][3][4]

Because the trials study different diseases, the entry rules are not the same in each one. A person may qualify for one study but not another, depending on age, diagnosis, and treatment plan.^{[1][2][3][4][5]}

Table of Contents

• What is PERTECHNETATE (99MTC) SODIUM?
• Medical Use in Early-Stage Ovarian Cancer
• How Does It Work?
• How is It Administered?
• Current Clinical Trial
• Who is Eligible for the Trial?
• Potential Benefits
• Precautions and Exclusions

What is PERTECHNETATE (99MTC) SODIUM?

PERTECHNETATE (99MTC) SODIUM, also known as Sodium pertechnetate (99mTc), is a radioactive substance used in medical imaging^[1]. It’s classified as a radiopharmaceutical, which means it’s a drug containing a radioactive isotope used for diagnostic or therapeutic purposes in nuclear medicine.

Medical Use in Early-Stage Ovarian Cancer

This substance is being studied for its potential use in detecting sentinel lymph nodes in patients with early-stage epithelial ovarian cancer^[1]. Epithelial ovarian cancer is a type of cancer that begins in the cells lining the ovaries. Early detection of cancer spread to lymph nodes is crucial for proper staging and treatment planning.

How Does It Work?

PERTECHNETATE (99MTC) SODIUM works as a tracer. When injected near the tumor site, it travels through the lymphatic system and collects in the sentinel lymph nodes – the first lymph nodes where cancer cells are likely to spread^[1]. Special cameras can then detect the radioactive signal, helping surgeons locate these important nodes.

How is It Administered?

The drug is administered as an injectable solution^[1]. It’s typically injected near the tumor site before surgery. The maximum daily dose is 400,000,000 Bq (becquerels), which is a unit used to measure radioactivity^[1].

Current Clinical Trial

A clinical trial is currently underway to evaluate the effectiveness of PERTECHNETATE (99MTC) SODIUM in sentinel node detection for early-stage ovarian cancer^[1]. The study aims to:

• Assess how well the tracer can detect sentinel lymph nodes
• Evaluate the precision of sentinel lymph node detection
• Study the lymphatic drainage patterns in ovarian cancer
• Compare the performance of different detection techniques
• Examine the anatomical distribution of sentinel lymph nodes

Who is Eligible for the Trial?

The trial is open to patients who meet specific criteria^[1]:

• Women with suspected or confirmed early-stage epithelial ovarian cancer
• No evidence of cancer spread to lymph nodes or distant sites on imaging
• Able to undergo surgery
• 18 years of age or older
• Not pregnant or breastfeeding

Potential Benefits

If successful, this technique could offer several benefits^[1]:

• More accurate staging of ovarian cancer
• Improved detection of small metastases in lymph nodes
• Potentially less extensive surgery if unnecessary lymph node removal can be avoided
• Better understanding of how ovarian cancer spreads through the lymphatic system

Precautions and Exclusions

Certain conditions may prevent participation in the trial^[1]:

• Advanced stage ovarian cancer (FIGO stage III or IV)
• History of vascular surgery or radiation therapy in the pelvic or para-aortic area
• Hypersensitivity to the active ingredient or iodine allergy
• Clinical hyperthyroidism or certain thyroid conditions

It’s important to note that while this treatment shows promise, it’s still under investigation. Patients should discuss all potential risks and benefits with their healthcare provider before considering participation in any clinical trial.

Table of Contents

• What is Noradrenaline Tartrate?
• Medical Uses
• How is it Administered?
• Potential Side Effects
• Precautions and Contraindications
• Current Research

What is Noradrenaline Tartrate?

Noradrenaline Tartrate, also known as Norepinephrine Bitartrate, is a medication used to treat various medical conditions, primarily those involving low blood pressure^[1]. It is a synthetic version of norepinephrine, a naturally occurring hormone and neurotransmitter in the body. Noradrenaline plays a crucial role in the body’s “fight or flight” response and helps regulate blood pressure, heart rate, and blood flow to vital organs.

Medical Uses

Noradrenaline Tartrate is primarily used in critical care settings to treat conditions such as:

• Shock: It is used to treat various types of shock, including cardiogenic shock (resulting from heart problems) and vasoplegic syndrome (a type of shock that can occur after cardiac surgery)^[2].
• Hypotension: It helps raise blood pressure in patients with dangerously low blood pressure^[3].
• Cardiac Arrest: It may be used as part of the treatment protocol for cardiac arrest^[4].
• Organ Support: In critical situations, it helps maintain blood flow to vital organs^[5].

How is it Administered?

Noradrenaline Tartrate is typically administered intravenously (through a vein) in a hospital setting, usually in an intensive care unit (ICU) or during surgery. It is given as a continuous infusion, with the dose carefully adjusted based on the patient’s response and blood pressure readings^[6]. The medication is diluted in a solution before administration to ensure proper dosing and to minimize the risk of side effects.

Potential Side Effects

While Noradrenaline Tartrate is a life-saving medication, it can cause side effects, especially if not administered correctly. Some potential side effects include:

• Hypertension: Excessively high blood pressure
• Arrhythmias: Irregular heart rhythms
• Tissue Ischemia: Reduced blood flow to certain tissues, particularly in the extremities
• Anxiety: Feelings of nervousness or restlessness
• Headache
• Nausea

Healthcare providers closely monitor patients receiving Noradrenaline Tartrate to minimize these risks and adjust the dosage as needed^[7].

Precautions and Contraindications

Noradrenaline Tartrate should be used with caution in certain situations:

• Pregnancy: It should only be used if the potential benefit justifies the potential risk to the fetus^[8].
• Heart Conditions: Patients with certain heart conditions may be at higher risk of complications.
• Interactions: It can interact with certain medications, including some antidepressants and anesthetics.

The medication is contraindicated in patients with known hypersensitivity to noradrenaline or any of its components^[9].

Current Research

Ongoing research is exploring new applications and optimizing the use of Noradrenaline Tartrate:

• Vasoplegic Syndrome: A study is comparing the effectiveness of vasopressin versus noradrenaline in managing patients with vasoplegic syndrome undergoing cardiac surgery^[10].
• Acute Kidney Injury: Research is investigating whether low-dose arginine-vasopressin supplementation with noradrenaline can reduce acute kidney injury after liver transplantation^[11].
• Stroke Treatment: A trial is exploring the use of noradrenaline to induce hypertension in patients with acute progressive stroke, aiming to improve outcomes^[12].
• Cardiogenic Shock: A study is examining whether a strategy of reduced noradrenaline use can improve outcomes in patients with cardiogenic shock following acute myocardial infarction^[13].

These studies aim to refine the use of Noradrenaline Tartrate and potentially expand its applications in critical care medicine.

Table of Contents

• What is N-Acetylhistidine?
• Custodiol-N: A New Organ Preservation Solution
• Uses of N-Acetylhistidine in Organ Transplantation
• Potential Benefits of N-Acetylhistidine
• Ongoing Research and Clinical Trials
• Conclusion

What is N-Acetylhistidine?

N-Acetylhistidine is a chemical compound that is being studied for its potential benefits in organ preservation during transplantation procedures. It is a modified form of the amino acid histidine, with an acetyl group attached to it. This compound is one of the key ingredients in a new organ preservation solution called Custodiol-N.^[1]

Custodiol-N: A New Organ Preservation Solution

Custodiol-N is an advanced organ preservation solution that contains N-acetylhistidine along with several other components. This solution is designed to protect organs during the transplantation process, from the time they are removed from the donor until they are implanted in the recipient. Custodiol-N is being compared to the standard Custodiol solution in various clinical trials to assess its effectiveness and safety.^[2]

Uses of N-Acetylhistidine in Organ Transplantation

N-Acetylhistidine, as part of the Custodiol-N solution, is being investigated for use in several types of organ transplantation:

• Heart transplantation: Studies are examining its use in pediatric heart transplants to see if it can improve outcomes for children receiving new hearts.^[1]
• Liver transplantation: Research is ongoing to determine if Custodiol-N can better preserve liver function during transplantation.^[3]
• Kidney transplantation: Clinical trials are assessing the effectiveness of Custodiol-N in preserving kidneys for transplant.^[4]
• Pancreas transplantation: The solution is also being studied for its potential benefits in pancreas preservation during transplant procedures.^[4]

Potential Benefits of N-Acetylhistidine

While research is still ongoing, N-acetylhistidine as part of the Custodiol-N solution may offer several potential benefits:

• Improved organ preservation: It may help protect organs from damage during the transplantation process, potentially leading to better function after transplant.^[2]
• Reduced complications: By potentially improving organ preservation, it might help reduce post-transplant complications and improve overall outcomes.^[3]
• Extended preservation time: There is hope that Custodiol-N might allow for longer preservation times, which could improve logistics for organ transplantation.^[4]

Ongoing Research and Clinical Trials

Several clinical trials are currently underway to evaluate the safety and effectiveness of Custodiol-N, which contains N-acetylhistidine:

• A study comparing Custodiol-N to standard Custodiol in pediatric heart transplantation.^[1]
• A trial examining the use of Custodiol-N in liver transplantation, focusing on markers of liver function and complications after transplant.^[3]
• A large study comparing Custodiol-N to Custodiol in kidney, liver, and pancreas transplantation.^[4]

These studies are measuring various outcomes, including organ function, complication rates, and patient survival, to determine if Custodiol-N offers advantages over current preservation methods.

Conclusion

N-Acetylhistidine, as a component of the Custodiol-N organ preservation solution, shows promise in improving outcomes for organ transplant recipients. While research is still ongoing, early studies suggest that it may help better protect organs during the transplantation process. As clinical trials progress, we will learn more about the potential benefits and any possible risks associated with this new preservation solution. Patients awaiting organ transplants or those interested in transplant medicine should stay informed about these developments, as they may lead to improved transplant procedures in the future.

Table of Contents

• What is Custodiol-N?
• How Custodiol-N Works
• Uses of Custodiol-N
• Ongoing Research
• Potential Benefits
• Safety and Side Effects
• Conclusion

What is Custodiol-N?

Custodiol-N is a new organ preservation solution being studied for use in organ transplantation. It is an improved version of an existing solution called Custodiol. Organ preservation solutions are special liquids used to protect and preserve organs after they are removed from a donor and before they are transplanted into a recipient.^[1]

The active ingredients in Custodiol-N include amino acids like alanine, arginine, and histidine, as well as other substances like deferoxamine, sucrose, and various electrolytes. It also contains a unique compound called N-hydroxy-3,4-dimethoxy-N-methyl-benzamide (also known as LK-614).^[1]

How Custodiol-N Works

Custodiol-N is designed to protect organs during the time between removal from the donor and transplantation into the recipient. This period is called cold ischemia time. The solution works in several ways:

• It cools the organ to slow down its metabolism
• It provides nutrients to support the organ’s cells
• It helps prevent cell swelling and damage
• It protects against harmful effects of oxygen deprivation

The goal is to keep the organ as healthy as possible until it can be transplanted and start functioning in the recipient’s body.^[2]

Uses of Custodiol-N

Custodiol-N is being studied for use in preserving several types of organs for transplantation:

• Hearts
• Livers
• Kidneys
• Pancreas

It is used to flush the organ after removal from the donor and to store the organ during transport to the recipient.^[3]

Ongoing Research

Several clinical trials are currently underway to evaluate the safety and effectiveness of Custodiol-N compared to the standard Custodiol solution:

• A study in children undergoing heart transplantation^[1]
• A study in children having heart surgery for congenital heart defects^[2]
• A study in adults receiving kidney, liver, or pancreas transplants^[3]
• A study focused specifically on liver transplantation^[4]

These studies are looking at various outcomes to determine if Custodiol-N provides any advantages over the current standard solution.

Potential Benefits

Researchers hope that Custodiol-N may offer several potential benefits compared to existing organ preservation solutions:

• Better protection of the organ during cold storage
• Improved organ function after transplantation
• Reduced risk of complications like delayed graft function
• Possibility of longer preservation times

However, these potential benefits still need to be proven through the ongoing clinical trials.^[3][4]

Safety and Side Effects

A key focus of the current research is to assess the safety of Custodiol-N. Researchers are carefully monitoring for any adverse events or side effects in transplant recipients. So far, no major safety concerns have been reported, but the studies are still ongoing.^[1][2]

It’s important to note that Custodiol-N is not a medication taken by patients directly. It is used only by medical professionals during the organ transplantation process.

Conclusion

Custodiol-N represents an exciting area of research in organ transplantation. If proven effective, it could potentially improve outcomes for transplant recipients. However, more research is needed before it can be widely adopted. Patients awaiting or considering organ transplantation should discuss the latest developments and options with their transplant team.

Table of Contents

• What is Magnesium Chloride Hexahydrate?
• Medical Uses
• How is it Administered?
• Potential Benefits
• Possible Side Effects
• Ongoing Research

What is Magnesium Chloride Hexahydrate?

Magnesium chloride hexahydrate is an important electrolyte used in various medical treatments. It is a compound that contains magnesium, chloride, and water molecules. The term “hexahydrate” means it has six water molecules attached to each magnesium chloride molecule^[1].

This substance is often found in medical solutions used to maintain proper electrolyte balance in the body. Electrolytes are minerals in your blood and other bodily fluids that carry an electric charge. They are crucial for many bodily functions, including hydration, nerve and muscle function, and maintaining proper pH levels^[2].

Medical Uses

Magnesium chloride hexahydrate is used in various medical contexts, including:

• Electrolyte Solutions: It’s a key component in many intravenous (IV) fluids used to correct electrolyte imbalances or dehydration^[3].
• Cardiac Surgery: Solutions containing this compound are used in heart surgeries, particularly in cardioplegia solutions. These solutions help protect the heart during procedures that require stopping the heart temporarily^[4].
• Organ Preservation: It’s used in solutions designed to preserve organs for transplantation^[5].
• Neurosurgery: Some studies are investigating its use in fluids administered during brain surgeries^[6].

How is it Administered?

Magnesium chloride hexahydrate is typically administered in the following ways:

• Intravenous Infusion: This is the most common method, where the solution is slowly dripped into a vein^[7].
• Intravenous Bolus: In some cases, it may be given as a quicker injection into a vein^[7].
• Organ Perfusion: During organ transplantation or certain surgeries, it may be used to perfuse (flood) an organ with a protective solution^[5].

Potential Benefits

The use of magnesium chloride hexahydrate in medical treatments may offer several benefits:

• Electrolyte Balance: It helps maintain proper levels of essential minerals in the body^[2].
• Cardiac Protection: In heart surgeries, it may help protect the heart muscle from damage during procedures^[4].
• Organ Preservation: It’s part of solutions that help keep organs viable for transplantation^[5].
• Fluid Management: It’s used in solutions that help manage a patient’s fluid levels during and after surgery^[6].

Possible Side Effects

While magnesium chloride hexahydrate is generally safe when used as directed by healthcare professionals, it’s important to be aware of potential side effects:

• Electrolyte Imbalance: If not administered correctly, it could lead to imbalances in other electrolytes^[8].
• Fluid Overload: In some cases, excessive administration of fluids containing this compound could lead to fluid overload^[8].
• Allergic Reactions: Although rare, some individuals may have an allergic reaction to the solution^[8].

It’s important to note that these solutions are administered by healthcare professionals who carefully monitor patients for any adverse effects.

Ongoing Research

Several clinical trials are currently investigating the use of solutions containing magnesium chloride hexahydrate:

• Cardiac Surgery: Studies are comparing different cardioplegia solutions (including those with magnesium chloride hexahydrate) to see which provides better protection for the heart during surgery^[4].
• Neurosurgery: Researchers are looking at how these solutions might affect outcomes in brain surgeries^[6].
• Fluid Management: Some studies are investigating how different fluid management strategies (including those using magnesium chloride hexahydrate) might affect patient outcomes in various types of surgeries^[6].

These ongoing studies aim to improve our understanding of how best to use these solutions to benefit patients undergoing various medical procedures.

Table of contents

• Trial overview
• Study design and treatment groups
• Who can participate
• What the trial is measuring
• Trial status and size

Trial overview

The available trial studies MAGNESIUM L-ASPARTATE HYDROCHLORIDE TRIHYDRATE in people with postoperative hypoparathyroidism after thyroid surgery.^[1] The study is called “MAGNEFFICIENT” and it is described as a prospective, randomized, double-blind, placebo-controlled, single-center clinical trial.^[1]

The trial is authorised and is listed as a Phase 3 interventional study.^[1] The brief summary says the study is testing whether 8-day oral magnesium aspartate can reduce chronic postoperative hypoparathyroidism at 6 months.^[1]

Study design and treatment groups

This is a randomized study, which means people are assigned to treatment groups by chance.^[1] It is also double-blind, which means the participants and the study team do not know who receives the active treatment or the placebo during the study.^[1]

The trial compares two oral treatments: TROFOCARD® max and a placebo that has the same composition as the investigational product except for the active substance.^[1] A placebo is a look-alike treatment used to help show whether the study drug makes a real difference.^[1]

Who can participate

The study is focused on people with postoperative hypoparathyroidism after thyroid surgery.^[1] The source data does not give more detailed entry rules, such as age limits or other medical conditions.^[1]

This means the main target population is patients who developed this problem after having their thyroid removed or treated by surgery.^[1]

What the trial is measuring

The main endpoint is the incidence of chronic postoperative hypoparathyroidism 6 months after surgery.^[1] An endpoint is the main result a clinical trial measures to see if the treatment works.^[1]

The trial defines this outcome as persistently low corrected calcium and PTH values when vitamin D or calcium has not been stopped.^[1] Corrected calcium is a blood calcium value adjusted to give a more accurate result, and PTH means parathyroid hormone, which helps control calcium levels.^[1]

Trial status and size

The trial status is Authorised.^[1] The planned enrollment is 500 people, which means the study aims to include 500 participants in total.^[1]

The study is single-center, so it is being carried out at one study site.^[1] This type of design can help keep the study process consistent across all participants.^[1]

Table of Contents

• What is Lidocaine Hydrochloride Monohydrate?
• Medical Uses
• How is it Administered?
• Dosage Information
• Potential Side Effects
• Precautions and Contraindications
• Ongoing Research

What is Lidocaine Hydrochloride Monohydrate?

Lidocaine Hydrochloride Monohydrate is a medication that belongs to a class of drugs called local anesthetics^[1]. It works by blocking nerve signals in your body, which helps to reduce pain and discomfort in specific areas. This drug is commonly known by its shorter name, lidocaine. It’s important to note that lidocaine is different from general anesthetics, which make you unconscious during surgery. Instead, lidocaine keeps you awake but numbs a particular part of your body.

Medical Uses

Lidocaine has several important medical uses:

• Local anesthesia: It’s used to numb specific areas of the body during minor surgical procedures, dental work, or when inserting medical devices^[2].
• Pain relief: Lidocaine can help manage various types of pain, including post-surgical pain and certain chronic pain conditions.
• Cardiac arrhythmias: In some cases, lidocaine is used to treat irregular heartbeats^[2].
• Gastrointestinal issues: Research is being conducted on the use of oral lidocaine to prevent gastrointestinal disturbances in patients after abdominal surgery^[3].

How is it Administered?

Lidocaine can be administered in several ways, depending on its intended use:

• Injection: For local anesthesia, lidocaine is often injected directly into the area that needs to be numbed^[4].
• Topical application: It can be applied to the skin as a cream, ointment, or patch for localized pain relief.
• Intravenous (IV) use: In some medical settings, lidocaine may be given through an IV for certain heart conditions or as part of a pain management strategy^[5].
• Oral form: Some research is exploring the use of oral lidocaine for specific conditions, such as preventing gastrointestinal issues after surgery^[3].

Dosage Information

The dosage of lidocaine varies widely depending on its use, the specific formulation, and individual patient factors. For example:

• For local anesthesia, the dose can range from 1 to 5 mg/kg of body weight^[5].
• In research on oral lidocaine for gastrointestinal issues, doses up to 400 mg per day are being studied^[3].

It’s crucial to emphasize that lidocaine should only be administered by or under the supervision of a healthcare professional. They will determine the appropriate dose based on your specific situation, medical history, and other factors.

Potential Side Effects

Like all medications, lidocaine can cause side effects. Most side effects are mild and temporary, but some can be serious. Common side effects may include:

• Numbness or tingling at the application site
• Mild dizziness or lightheadedness
• Nausea
• Vomiting

More serious side effects, which require immediate medical attention, can include:

• Allergic reactions (rash, itching, swelling)
• Severe dizziness or fainting
• Irregular heartbeat
• Seizures
• Difficulty breathing

It’s important to report any unusual symptoms to your healthcare provider promptly^[6].

Precautions and Contraindications

Certain conditions or factors may affect the use of lidocaine:

• Allergies: If you’re allergic to lidocaine or similar local anesthetics, you should not use this medication.
• Liver or kidney disease: These conditions may affect how your body processes lidocaine.
• Heart conditions: Lidocaine can affect heart rhythm, so it should be used with caution in people with certain heart problems.
• Pregnancy and breastfeeding: The safety of lidocaine during pregnancy and breastfeeding should be discussed with a healthcare provider.

Always inform your healthcare provider about all medications you’re taking, including over-the-counter drugs and supplements, as they may interact with lidocaine^[6].

Ongoing Research

Lidocaine is being studied for various potential uses beyond its current applications. Some areas of ongoing research include:

• Gastrointestinal issues: A study is investigating the use of oral lidocaine to prevent gastrointestinal disturbances in patients after abdominal surgery^[3].
• Pain management: Researchers are exploring new ways to use lidocaine for managing different types of pain, including chronic pain conditions.
• Combination therapies: Studies are looking at how lidocaine might work in combination with other medications to enhance pain relief or reduce side effects.

These research efforts aim to expand our understanding of lidocaine’s potential benefits and optimize its use in medical care. However, it’s important to remember that research findings may not immediately translate into new approved uses, and any new applications would need to go through rigorous testing and regulatory approval processes before becoming widely available.

Table of Contents

• What is L-Histidine Hydrochloride?
• Role in Organ Preservation
• Custodiol and Custodiol-N
• Clinical Applications
• Ongoing Research
• Safety and Efficacy
• Conclusion

What is L-Histidine Hydrochloride?

L-Histidine Hydrochloride is an essential component found in organ preservation solutions used during transplantation procedures. It is a salt form of the amino acid L-Histidine, which plays a crucial role in maintaining the health and viability of organs during the preservation process^[1].

Role in Organ Preservation

In organ transplantation, preserving the organ’s function during the time between removal from the donor and implantation in the recipient is critical. L-Histidine Hydrochloride contributes to this process in several ways:

• pH Buffering: It helps maintain the optimal pH level in the preservation solution, preventing acidosis in the organ tissues.
• Antioxidant Properties: L-Histidine acts as an antioxidant, protecting the organ from damage caused by free radicals during storage and transport.
• Membrane Stabilization: It helps stabilize cell membranes, reducing the risk of cellular damage during the preservation period.

Custodiol and Custodiol-N

L-Histidine Hydrochloride is a key ingredient in two widely used organ preservation solutions: Custodiol and Custodiol-N^[2].

Custodiol, also known as HTK solution (Histidine-Tryptophan-Ketoglutarate), is a crystalloid cardioplegia and organ preservation solution. It contains L-Histidine, L-Histidine Hydrochloride, and other components such as tryptophan, potassium chloride, and mannitol^[3].

Custodiol-N is a newer formulation designed to potentially improve organ preservation outcomes. While its exact composition is not detailed in the provided information, it is being studied as an alternative to the standard Custodiol solution^[4].

Clinical Applications

L-Histidine Hydrochloride, as part of Custodiol and Custodiol-N solutions, is used in various transplantation procedures, including:

• Heart Transplantation: Used for myocardial protection during heart surgery and transplantation^[5].
• Kidney Transplantation: Helps preserve kidney function during the transplant process^[6].
• Liver Transplantation: Used to maintain liver viability during organ procurement and transplantation^[6].
• Pancreas Transplantation: Aids in preserving pancreatic tissue for transplantation, often in combination with kidney transplants^[6].

Ongoing Research

Several clinical trials are currently investigating the efficacy and safety of Custodiol and Custodiol-N solutions containing L-Histidine Hydrochloride:

• A study comparing Custodiol-N to standard Custodiol in pediatric heart transplantation^[7].
• Research on the use of Custodiol-N versus Custodiol in cardiac surgery for children with congenital heart defects^[8].
• A comparison of Custodiol crystalloid cardioplegia to Buckberg blood cardioplegia in major cardiac surgery^[9].
• A phase III study evaluating Custodiol-N against Custodiol in kidney, liver, and pancreas transplantation^[10].

Safety and Efficacy

The ongoing clinical trials aim to assess the safety and efficacy of L-Histidine Hydrochloride-containing solutions in various transplantation scenarios. Key aspects being evaluated include:

• Graft Function: Researchers are examining how well the preserved organs function after transplantation^[10].
• Organ Injury: Studies are measuring markers of organ damage to compare the protective effects of different preservation solutions^[10].
• Post-Operative Outcomes: Trials are tracking various outcomes such as mortality rates, graft survival, and complications^[7][8][9].
• Adverse Events: Continuous monitoring of adverse events is being conducted to ensure patient safety^[7][8].

Conclusion

L-Histidine Hydrochloride plays a vital role in organ preservation solutions used in transplantation procedures. As a component of Custodiol and Custodiol-N, it contributes to maintaining organ viability and function during the critical period between organ retrieval and implantation. Ongoing research aims to further optimize these solutions, potentially improving outcomes for transplant recipients. Patients awaiting or considering organ transplantation should discuss the latest developments in organ preservation techniques with their healthcare providers to understand how these advancements might impact their treatment.

Table of Contents

• Overview of the trials
• Ovarian cancer studies
• Liver disease and cirrhosis studies
• Septic shock and kidney injury study
• Other trials using Human Serum Albumin
• Main endpoints and what they mean
• Who may take part

Overview of the trials

The trial data show several studies of Human Serum Albumin in very different clinical settings, including cancer, liver disease, critical illness, and eye injury.^{[1][2][3][4][5][6]}

Most trials are Phase 3, with some Phase 2 studies and one Phase 1/2 trial.^{[1][2][3][4][5][6][7]}

These studies are interventional, which means researchers give a treatment or procedure and then measure the results.^{[1][2][3][4][5][6][7]}

Ovarian cancer studies

Two trials study sentinel lymph node detection in early-stage ovarian cancer, including epithelial ovarian cancer in early stages.^[1][2]

In these studies, Human Serum Albumin appears as part of the tracer or detection approach used during surgery or mapping of lymph nodes.^[1][2]

The main goal is to see how well the sentinel lymph node technique finds cancer spread, using measures such as the negative predictive value and the global detection rate.^[1][2]

One trial compares the sentinel node technique with pelvic and aortic lymphadenectomy, which is surgery to remove lymph nodes and use that as the gold standard for checking spread.^[1]

The ovarian cancer studies are in Phase 3 and Phase 2, with planned enrollment of 200 and 62 patients.^[1][2]

Liver disease and cirrhosis studies

Several trials focus on cirrhosis, which is long-term scarring of the liver, and its complications.^[3][4][5][6]

One Phase 3 study in critically ill patients with septic shock and high risk of acute kidney injury tests whether Human Serum Albumin can reduce severe kidney injury during the first 7 days after shock begins.^[3]

Another Phase 2 trial in decompensated cirrhosis studies a combination of Human Serum Albumin and enoxaparin, with a main focus on safety and tolerability, including treatment-emergent adverse events, pulmonary edema, severe thrombocytopenia, and major bleeding.^[4]

A Phase 3 trial in decompensated cirrhosis and AKI 1B or greater compares intravenous Human Serum Albumin with saline solution to see whether kidney function improves and whether acute kidney injury resolves.^[5]

Two related Phase 3 cirrhosis trials look at a personalized approach to Human Serum Albumin therapy and measure liver-related outcomes such as variceal bleeding, ascites, spontaneous bacterial peritonitis, infection needing hospitalization, acute kidney injury, and overt hepatic encephalopathy.^[6][7]

One of these cirrhosis studies was withdrawn, while the other remains authorised.^[6][7]

Another completed Phase 3 trial in cirrhosis with ACLF-1b, ACLF-2, or ACLF-3a studied whether standard medical treatment plus PE-A 5% improves 90-day overall survival compared with standard treatment alone.^[8]

Septic shock and kidney injury study

The septic shock trial is for critically ill patients with a high risk of acute kidney injury (AKI), which means sudden kidney damage.^[3]

The study measures the incidence of AKI reaching KDIGO stage 2-3 during the first 7 days after septic shock starts.^[3]

This is a Phase 3 randomized controlled trial, meaning patients are assigned to treatment groups by chance.^[3]

Other trials using Human Serum Albumin

One Phase 1/2 solid tumor trial includes Human Serum Albumin among several infusion drugs used in the study program.^[9]

This trial is mainly designed to test safety, dose-limiting toxicities, serious treatment-emergent adverse events, and anti-tumor activity in patients with recurrent and/or refractory solid tumors.^[9]

Another Phase 2 trial in severe eye chemical burns uses ALBUTEIN 50 g/L as part of a subconjunctival injection protocol with mesenchymal stromal cells, and the main endpoint is absence of corneal perforation.^[10]

This eye study is focused on preserving the eyeball 6 months after the first injection.^[10]

Main endpoints and what they mean

A primary outcome is the main result the researchers want to measure.^[1]

In these trials, primary outcomes include negative predictive value, detection rate, incidence of severe AKI, safety events, kidney recovery, overall survival, and absence of corneal perforation.^{[1][2][3][4][5][8][9][10]}

Some studies use terms like overall survival, which means how long people live after treatment starts, and objective response rate, which means how many patients have their tumors shrink or disappear.^[8][9]

Other studies look at liver-related events such as ascites, variceal bleeding, spontaneous bacterial peritonitis, and hepatic encephalopathy, which is confusion caused by severe liver disease.^[6][7]

Who may take part

The studies include people with early-stage ovarian cancer, cirrhosis, decompensated cirrhosis, septic shock, acute kidney injury, recurrent and/or refractory solid tumors, and severe eye chemical burns.^{[1][2][3][4][5][6][7][8][9][10]}

Some trials are for hospitalized or critically ill patients, while others focus on surgical or cancer staging settings.^[1][3][5][8]

Each study has its own rules for who can join, based on the disease stage and the clinical situation described in the trial record.^[1][3][5][8]

Table of Contents

• What is HUMAN CANCELLOUS BONE?
• Medical Conditions Treated
• How It Works
• Eligibility for Treatment
• Treatment Process
• Expected Outcomes
• Safety and Side Effects

What is HUMAN CANCELLOUS BONE?

HUMAN CANCELLOUS BONE, also known as Spongioflex^[1], is a medical product used for partial meniscal replacement in patients with incomplete meniscal loss. It is classified as a transplant of human origin, which means it is derived from human tissue. This product is being studied as a potential treatment for certain knee conditions.

Medical Conditions Treated

The primary medical condition that HUMAN CANCELLOUS BONE aims to treat is incomplete meniscal loss. This condition can occur due to various reasons, including:^[1]

• Meniscus tears: These can include bucket handle tears of the medial or lateral meniscus
• Derangement of the meniscus: This refers to structural problems in different parts of the meniscus, such as the anterior horn, posterior horn, or the entire medial or lateral meniscus
• Old injuries to the meniscus that have not healed properly

The meniscus is a C-shaped piece of cartilage in your knee that acts as a cushion between your thighbone and shinbone. When it’s damaged or partially missing, it can cause pain and affect the knee’s functionality.

How It Works

HUMAN CANCELLOUS BONE is used as a partial meniscal replacement. This means it’s designed to replace the part of the meniscus that has been lost or damaged. The procedure aims to:^[1]

• Improve the functionality of the meniscus
• Reduce pain in the affected knee
• Potentially slow down the progression of osteoarthritis in the knee

The product is a sterile allograft, which means it’s tissue taken from a donor and processed to be safe for use in another person’s body.

Eligibility for Treatment

Not everyone with meniscus problems is eligible for this treatment. Some key eligibility criteria include:^[1]

• Partial loss of portions of the lateral or medial meniscus with associated joint line pain
• Sufficient standing of the peripheral rim of the meniscus
• Age between 18 and 60 years
• Body Mass Index (BMI) less than or equal to 30 kg/m²

Certain conditions may make a person ineligible for this treatment, such as:

• Chronic pain conditions
• Inflammatory arthritis or synovitis in the affected knee
• Advanced cartilage damage or osteoarthritis in the affected knee compartment
• Significant knee extension deficit or limited flexion
• Pregnancy (for patients considering surgery)

Treatment Process

The treatment involves a surgical procedure to implant the HUMAN CANCELLOUS BONE material. After the surgery:^[1]

1. Patients will undergo regular evaluations to assess the functionality of their knee
2. MRI (Magnetic Resonance Imaging) scans will be performed at various intervals to evaluate the condition of the meniscus and the knee joint
3. Patients will be asked to complete questionnaires about their pain levels and overall knee function

Expected Outcomes

The main goals of this treatment are:^[1]

• Improvement in knee functionality
• Reduction in pain
• Better scores on standardized knee assessment tools (like KOOS and IKDC)
• Potential slowing of osteoarthritis progression

Patient satisfaction will be assessed after 2 and 5 years following the surgery.

Safety and Side Effects

As with any medical procedure, there are potential risks and side effects. The study is designed to monitor:^[1]

• The type, frequency, and severity of treatment-related adverse events
• Any serious adverse events that may occur

It’s important to discuss potential risks and benefits with your healthcare provider before considering this treatment.

Table of Contents

• Introduction
• Medical Uses
• How It Works
• Administration
• Safety and Side Effects
• Ongoing Research
• Conclusion

Introduction

GALLIUM (68GA) CHLORIDE is a radiopharmaceutical precursor used in medical imaging. It is a radioactive form of gallium that can be combined with other substances to create specialized imaging agents. These agents are used in a type of medical imaging called Positron Emission Tomography (PET), often combined with Computed Tomography (CT) scans^[1].

Medical Uses

GALLIUM (68GA) CHLORIDE is being studied for use in various medical conditions:

• Perianal Crohn’s Disease: Used to visualize and quantify fibroblast activation patterns during the healing of perianal fistulas in Crohn’s disease patients^[2].
• Early Rectal Cancer: Utilized to detect lymph node metastasis in patients with early-stage rectal cancer^[3].
• Ulcerative Colitis: Employed to detect and monitor intestinal fibrosis in patients with ulcerative colitis^[4].
• Chronic Inflammatory Disorders: Used to image various chronic inflammatory and fibrotic diseases^[5].
• Pulmonary Aspergillosis: Investigated for visualizing pulmonary Aspergillus infections^[6].
• Parotid Gland Cancer: Studied for sentinel lymph node biopsy in patients with parotid gland carcinoma^[7].
• Occult Cancer Screening: Researched for screening hidden cancers in patients with unexplained blood clots^[8].

How It Works

GALLIUM (68GA) CHLORIDE works by emitting positrons, which are detected by PET scanners. When combined with specific targeting molecules, it can accumulate in areas of disease or inflammation. This allows doctors to visualize these areas on PET/CT scans, providing valuable information about the location and extent of various conditions^[1].

For example, in Crohn’s disease studies, GALLIUM (68GA) CHLORIDE is combined with a substance called FAPI-46. This combination targets fibroblast activation protein (FAP), which is involved in inflammation and tissue healing. By visualizing FAP, doctors can assess the healing process of fistulas in Crohn’s disease patients^[2].

Administration

GALLIUM (68GA) CHLORIDE is typically administered intravenously (through a vein). The dose can vary depending on the specific use and the patient’s condition. In most studies, the maximum daily dose ranges from 100 to 500 MBq (megabecquerels), a unit used to measure radioactivity^[2][3][4].

After administration, patients usually undergo PET/CT imaging within a few hours. The exact timing can vary depending on the specific condition being studied and the targeting molecule used with GALLIUM (68GA) CHLORIDE^[5].

Safety and Side Effects

As a radiopharmaceutical, GALLIUM (68GA) CHLORIDE is used in very small quantities and is generally considered safe. However, it does involve exposure to a small amount of radiation. The benefits of the diagnostic information obtained are typically considered to outweigh the risks of this radiation exposure^[1].

Potential side effects may include:

• Allergic reactions (rare)
• Mild discomfort at the injection site

Patients who are pregnant, breastfeeding, or have severe kidney dysfunction may not be suitable candidates for procedures using GALLIUM (68GA) CHLORIDE. Always inform your healthcare provider about your full medical history and any medications you’re taking^[6].

Ongoing Research

Several clinical trials are currently underway to further investigate the use of GALLIUM (68GA) CHLORIDE in various conditions:

• The PERSIST study is examining its use in Crohn’s disease fistulas^[2].
• The FARE trial is investigating its effectiveness in detecting lymph node metastasis in early rectal cancer^[3].
• The INTERACT study is exploring its potential in monitoring intestinal fibrosis in ulcerative colitis^[4].
• The PARADISE study is looking at its use in various chronic inflammatory and fibrotic diseases^[5].
• The MIRAGE study is assessing its potential in imaging pulmonary aspergillosis^[6].

Conclusion

GALLIUM (68GA) CHLORIDE is a promising radiopharmaceutical precursor with a wide range of potential applications in medical imaging. Its ability to be combined with various targeting molecules makes it a versatile tool for visualizing different disease processes. As research continues, it may become an increasingly important part of diagnosis and treatment planning for conditions ranging from inflammatory bowel diseases to cancer. Patients interested in procedures using GALLIUM (68GA) CHLORIDE should discuss the potential benefits and risks with their healthcare providers.

Table of Contents

• What is SGM-101?
• How does SGM-101 work?
• What types of cancer can SGM-101 detect?
• How is SGM-101 used during surgery?
• What are the potential benefits of using SGM-101?
• What are the side effects and risks?
• Current research and clinical trials

What is SGM-101?

SGM-101 is an innovative medical imaging agent being studied for use in cancer detection and surgery. It is classified as a chimeric monoclonal antibody that targets a protein called carcinoembryonic antigen (CEA), which is found in high levels in certain types of cancer cells^[1]. The antibody is attached to a fluorescent dye that glows when exposed to near-infrared light, allowing surgeons to visualize cancer cells during operations.

How does SGM-101 work?

SGM-101 works through a process called fluorescence-guided surgery. Here’s how it functions:

1. The drug is injected into the patient’s bloodstream before surgery.
2. It circulates through the body and attaches to cancer cells that express CEA.
3. During surgery, doctors use a special camera that can detect near-infrared light.
4. When this light is shined on the surgical area, any cancer cells with SGM-101 attached will glow, making them visible to the surgeon.

This allows surgeons to more accurately identify and remove cancerous tissue, potentially improving the success of cancer surgeries^[2].

What types of cancer can SGM-101 detect?

Based on current research, SGM-101 is being studied for use in several types of cancer, including:

• Colorectal cancer, including liver metastases from colorectal cancer^[1]
• Pancreatic cancer^[3]
• Brain metastases from colorectal cancer^[4]
• Early rectal cancer^[5]

These cancers often express high levels of CEA, making them good targets for SGM-101 imaging.

How is SGM-101 used during surgery?

SGM-101 is typically administered to patients via intravenous injection or infusion before surgery. The timing can vary, but it’s usually given 1-4 days before the operation. During surgery, doctors use a special camera system called the Quest Spectrum System to detect the fluorescent signal from SGM-101^[2].

The fluorescent imaging helps surgeons in several ways:

• Identifying the primary tumor and its borders
• Detecting small metastases that might not be visible to the naked eye
• Assessing whether all cancerous tissue has been removed
• Guiding decisions about how much tissue to remove

What are the potential benefits of using SGM-101?

The use of SGM-101 in cancer surgery could potentially offer several benefits:

• Improved tumor detection: It may help surgeons find small tumors or metastases that might be missed with conventional techniques.
• More complete tumor removal: By clearly highlighting cancer cells, it could help ensure that all cancerous tissue is removed during surgery.
• Reduced removal of healthy tissue: The precise imaging could help surgeons avoid removing unnecessary amounts of healthy tissue.
• Better surgical outcomes: These factors combined could potentially lead to more successful surgeries and better outcomes for patients.

What are the side effects and risks?

As SGM-101 is still in clinical trials, the full range of potential side effects is not yet known. However, some possible risks include:

• Allergic reactions: As with any drug, some people may be allergic to SGM-101. Patients with a history of severe allergic reactions are typically excluded from trials^[3].
• False positives: There’s a possibility that SGM-101 could sometimes highlight non-cancerous tissue, potentially leading to unnecessary removal of healthy tissue.
• False negatives: Conversely, not all cancer cells may be detected, which could result in some cancerous tissue being left behind.

It’s important to note that SGM-101 is still being studied, and researchers are carefully monitoring for any potential side effects or risks.

Current research and clinical trials

Several clinical trials are currently underway to study the effectiveness and safety of SGM-101 in different cancer types:

• A study on fluorescence-guided surgery for colorectal liver metastases^[1]
• A trial investigating SGM-101 for imaging pancreatic cancer during surgery^[3]
• Research on using SGM-101 to detect brain metastases from colorectal cancer^[4]
• A study on SGM-101 for detecting early rectal cancer^[5]

These trials are assessing various aspects of SGM-101’s performance, including its ability to accurately detect cancer cells, its impact on surgical decision-making, and its safety profile.

While SGM-101 shows promise, it’s important to remember that it’s still an experimental drug. More research is needed to fully understand its benefits and risks before it can be approved for widespread use. Patients interested in SGM-101 should discuss current clinical trial opportunities with their healthcare providers.

Table of Contents

• What is BUPIVACAINE HYDROCHLORIDE, ANHYDROUS?
• What is it used for?
• How is it administered?
• Effectiveness
• Potential Side Effects
• Precautions and Contraindications
• Ongoing Research

What is BUPIVACAINE HYDROCHLORIDE, ANHYDROUS?

BUPIVACAINE HYDROCHLORIDE, ANHYDROUS is a local anesthetic medication used to numb specific areas of the body during various medical procedures^[1]. It belongs to a class of drugs called amide local anesthetics. This medication works by blocking nerve signals in your body, which helps prevent pain sensations in specific areas.

What is it used for?

Bupivacaine is used in a variety of medical procedures and conditions, including:

• Surgical anesthesia: It’s commonly used during surgeries to provide localized pain relief^[1].
• Postoperative pain management: It can be used to manage pain after various types of surgeries, including colorectal and breast cancer surgeries^[3][4].
• Obstetric procedures: It’s used in spinal anesthesia for procedures like external cephalic version (turning a breech baby)^[5].
• Urological surgeries: It’s utilized in procedures such as robot-assisted upper urinary tract surgery^[1].

How is it administered?

Bupivacaine can be administered in several ways, depending on the specific procedure and the area that needs to be numbed:

• Intrathecal use: Injected into the fluid surrounding the spinal cord^[1].
• Parenteral use: Injected into body tissues^[3].
• Continuous wound infiltration: Delivered directly into the surgical site for ongoing pain relief^[3].
• Nerve blocks: Injected near specific nerves to block pain signals, such as in pectoral nerve (PECS II) blocks for breast surgeries^[4].

The medication is always administered by a healthcare professional in a controlled medical setting.

Effectiveness

Research suggests that bupivacaine is effective in managing pain across various surgical procedures:

• In colorectal surgery, continuous wound infiltration with bupivacaine may improve postoperative recovery and reduce pain levels^[3].
• For breast cancer surgery, studies are comparing the effectiveness of bupivacaine to other long-acting local anesthetics for postoperative pain control^[4].
• In obstetrics, spinal anesthesia with bupivacaine is being studied for its potential to increase the success rate of external cephalic version procedures^[5].

Potential Side Effects

While bupivacaine is generally considered safe when used as directed, it can have some side effects. These may include:

• Hypotension (low blood pressure)
• Bradycardia (slow heart rate)
• Nausea and vomiting
• Temporary numbness or weakness in the affected area
• In rare cases, allergic reactions or local anesthetic systemic toxicity (LAST)^[4]

It’s important to note that these side effects are typically monitored and managed by healthcare professionals during and after the procedure.

Precautions and Contraindications

Bupivacaine may not be suitable for everyone. It should be used with caution or avoided in patients with:

• Allergies to local anesthetics of the amide type
• Severe heart problems
• Bleeding disorders or those on anticoagulant medications
• Infections at the injection site
• Certain neurological conditions

Always inform your healthcare provider about your medical history and any medications you’re taking before receiving bupivacaine^[5].

Ongoing Research

Several clinical trials are currently exploring the use of bupivacaine in various medical contexts:

• Comparing its effectiveness to other pain management strategies in robot-assisted urological surgeries^[1].
• Evaluating its role in enhancing recovery after minimally invasive colorectal surgery^[3].
• Investigating its potential in improving the success rate of external cephalic version procedures in obstetrics^[5].

These ongoing studies aim to further optimize the use of bupivacaine in different medical procedures, potentially leading to improved patient outcomes and pain management strategies.

Table of Contents

• What is Botulinum Toxin Type A?
• Medical Conditions Treated
• How It Works
• How It’s Administered
• Efficacy
• Safety and Side Effects
• Duration of Effects
• Important Considerations

What is Botulinum Toxin Type A?

Botulinum Toxin Type A – Haemagglutinin Complex, also known as abobotulinumtoxinA, is a medical treatment derived from the bacterium Clostridium botulinum^[1]. It’s commonly referred to by brand names such as Dysport® or Azzalure®. This treatment is part of a class of medications called neurotoxins, which work by temporarily blocking nerve signals in specific areas of the body.

Medical Conditions Treated

Botulinum Toxin Type A is used to treat various medical conditions, including:

• Chronic migraine: For adults experiencing 15 or more headache days per month, with at least 8 being migraines^[2]
• Episodic migraine: For adults with 6-14 migraine days per month^[3]
• Upper limb spasticity: Muscle stiffness and tightness in the arm, often following a stroke^[4]
• Spastic equinovarus: A condition causing foot and ankle deformity in stroke patients^[5]
• Dystonic tremor syndrome: Involuntary muscle contractions causing tremors^[6]
• Moderate to severe upper facial lines: Including glabellar (frown) lines, forehead lines, and lateral canthal lines (crow’s feet)^[7]

How It Works

Botulinum Toxin Type A works by temporarily blocking the nerve signals that cause muscle contractions. When injected into specific muscles, it reduces their activity, which can help alleviate symptoms in various conditions^[1]. For example, in migraines, it’s believed to work by blocking pain signals and reducing muscle tension that may contribute to headaches^[2].

How It’s Administered

The treatment is administered through injections directly into the affected muscles. The specific injection sites and doses vary depending on the condition being treated. For instance:

• For chronic migraine, injections are typically given in multiple sites around the head and neck^[2]
• For upper limb spasticity, injections target specific muscles in the arm^[4]
• For facial lines, injections are made into the muscles responsible for creating wrinkles^[7]

The procedure is usually performed in a doctor’s office and takes about 10-15 minutes. Most patients describe the injections as feeling like small pinches.

Efficacy

Clinical trials have shown Botulinum Toxin Type A to be effective for its approved uses:

• For chronic migraine, it can significantly reduce the number of headache days per month^[2]
• In upper limb spasticity, it can improve muscle tone and function^[4]
• For facial lines, it can provide noticeable improvement in the appearance of wrinkles^[7]

However, individual responses can vary, and it may take several days to a few weeks to see the full effects of the treatment.

Safety and Side Effects

Botulinum Toxin Type A is generally considered safe when administered by a qualified healthcare professional. However, like all medications, it can cause side effects. Common side effects may include:

• Injection site reactions (pain, swelling, redness)
• Headache
• Muscle weakness near the injection site
• Drooping eyelids (when used for facial treatments)

Serious side effects are rare but can include difficulty swallowing or breathing. It’s important to report any unusual symptoms to your healthcare provider immediately^[1].

Duration of Effects

The effects of Botulinum Toxin Type A are temporary. Depending on the condition being treated, the effects typically last 3-6 months. For example:

• For chronic migraine, treatments are usually given every 12 weeks^[2]
• For facial lines, effects may last up to 4 months^[7]

After the effects wear off, repeat treatments are necessary to maintain the benefits.

Important Considerations

Before receiving Botulinum Toxin Type A treatment, it’s important to:

• Inform your doctor about all medications you’re taking, especially those that affect muscle function or blood clotting
• Disclose any history of neuromuscular disorders
• Avoid alcohol and blood-thinning medications for a few days before treatment
• Be aware that pregnancy and breastfeeding are typically contraindications for this treatment

Remember, Botulinum Toxin Type A should only be administered by qualified healthcare professionals in appropriate medical settings. Always follow your doctor’s instructions for the best and safest results.

Table of contents

• Trial overview
• Who is being studied
• Study goals and endpoints
• Trial phase and design
• What participants should know

Trial overview

The available trial is a first-in-human imaging study of ANTI-GD2-800CW in patients with neuroblastoma.^[1] It is listed as a phase Ib/II study and is authorised.^[1]

This study is interventional, which means researchers give the study agent and then measure the results.^[1] The trial plans to enroll 22 participants.^[1]

Who is being studied

The trial is focused on pediatric patients with neuroblastoma.^[1] Neuroblastoma is the condition listed in the trial data, and it is the only target disease named for this study.^[1]

The trial description says it is meant for children with neuroblastoma, so the study population is pediatric rather than adult.^[1]

Study goals and endpoints

The main goal is to establish the recommended phase 2 dose (RP2D) based on safety and efficacy.^[1] RP2D means the dose chosen for later studies after early results show it is suitable.^[1]

Another key goal is to study safety by looking for treatment-related new adverse events.^[1] Adverse events are unwanted medical problems that happen during a study.^[1]

The primary outcome also includes whether the tumor has a tumor to background ratio (TBR) of at least 2.0 ex vivo and whether it is good enough to detect during surgery.^[1] TBR compares the fluorescence signal from the tumor with the signal from normal tissue, and ex vivo means the test is done outside the body on tissue that has been removed.^[1]

The background signal is measured in healthy kidney, liver, and surrounding background tissue.^[1] This helps researchers see whether the tumor stands out clearly from normal tissue during imaging.^[1]

Trial phase and design

The study is described as Phase 1/2 and also as Phase Ib/II.^[1] This means it is an early-stage trial that combines safety testing with an early look at whether the imaging approach works well.^[1]

The intervention listed is ANTI-GD2-800CW given as an IV infusion, which means it is administered through a vein.^[1] The study is not described as a drug treatment trial for cancer control, but as an imaging study to help detect tumors.^[1]

What participants should know

Based on the trial data, participation is limited to children with neuroblastoma in an early imaging study.^[1] The study is looking at both safety and how well the tumor can be seen, especially around the time of surgery.^[1]

The main results will help researchers decide whether ANTI-GD2-800CW should move forward in later studies and at what dose it should be studied next.^[1]

Table of Contents

• What is Anhydrous Lidocaine Hydrochloride?
• Medical Uses
• How it’s Administered
• Effectiveness
• Potential Side Effects
• Precautions and Contraindications
• Ongoing Research

What is Anhydrous Lidocaine Hydrochloride?

Anhydrous Lidocaine Hydrochloride is a widely used local anesthetic medication. It belongs to a class of drugs called amide-type local anesthetics^[1]. The term “anhydrous” means it doesn’t contain water, while “hydrochloride” refers to the salt form of the drug. Lidocaine works by temporarily blocking nerve signals in a specific area, which results in numbness and pain relief.

Medical Uses

Lidocaine has a variety of medical applications, including:

• Minor breast cancer surgery: It’s used as part of a nerve block technique called intertransverse process block to provide pain relief during and after surgery^[1].
• Treatment of Dupuytren’s contracture: This is a condition where fingers bend towards the palm and can’t be fully straightened. Lidocaine is used for pain relief during a procedure called percutaneous needle fasciotomy^[2].
• Obstetric procedures: It’s used for pain relief during repair of perineal tears after childbirth^[3].
• Eye procedures: Lidocaine is used as an anesthetic for various eye surgeries and procedures^[4][5].
• Urological surgery: It’s used in combination with other medications for pain management during and after robotic-assisted upper urinary tract surgery^[6].
• Knee osteoarthritis treatment: Lidocaine is being studied for its potential use in a procedure called genicular artery embolization for knee pain relief^[7].

How it’s Administered

Lidocaine can be administered in several ways, depending on the specific medical procedure:

• Injection: It can be injected directly into the area that needs to be numbed, such as for nerve blocks or local anesthesia^[1][2].
• Topical application: For some procedures, lidocaine may be applied as a gel or cream on the skin or mucous membranes^[3].
• Eye drops: For eye procedures, lidocaine can be administered as eye drops^[4][5].
• Intravenous infusion: In some cases, lidocaine may be given through an IV for systemic pain relief^[6].

Effectiveness

Lidocaine is generally considered very effective for local anesthesia and pain relief. Its effectiveness can vary depending on the specific use and individual patient factors. For example:

• In breast cancer surgery, researchers are studying whether lidocaine as part of a nerve block technique can effectively reduce pain and improve recovery^[1].
• For eye procedures, studies are comparing the effectiveness of lidocaine gel to other anesthetic eye drops^[4][5].
• In knee osteoarthritis treatment, researchers are investigating whether lidocaine used in a new procedure can provide long-term pain relief^[7].

Potential Side Effects

While lidocaine is generally safe when used as directed, it can have some side effects. These may include:

• Numbness or tingling at the application site
• Mild skin irritation or redness
• In rare cases, allergic reactions
• If too much is absorbed into the bloodstream, it could potentially cause more serious side effects like dizziness, seizures, or heart rhythm problems^[6]

Precautions and Contraindications

Lidocaine may not be suitable for everyone. Precautions and contraindications include:

• Allergy to lidocaine or similar local anesthetics
• Severe liver or kidney disease
• Certain heart conditions
• Pregnancy or breastfeeding (should be used with caution)
• Certain medications that may interact with lidocaine^[6][7]

Ongoing Research

Several clinical trials are currently exploring new uses and applications for lidocaine:

• Its role in improving recovery after robotic-assisted urological surgery^[6]
• Comparison of lidocaine gel to other anesthetic eye drops for various eye procedures^[4][5]
• Its potential use in a new procedure for treating knee osteoarthritis pain^[7]

These studies aim to further understand the benefits and optimal uses of lidocaine in different medical contexts.

After the transplant, the treatment is given over about one year. One group receives a reduced dose of the immune-suppressing medicine, while the other group receives the standard dose. During the study, the health of the transplanted kidney is followed, and the study team looks for signs of rejection, infection, kidney function changes, and other serious problems. A biopsy, which is a small sample taken from the kidney, may be used to check for rejection.

The study also looks for dnDSAs, which are new antibodies made by the body against the transplanted kidney, and eGFR, a blood test that helps show how well the kidney is working. Other terms used in the study include ddcfDNA, a small amount of DNA from the transplanted kidney that can be found in the blood, and dialysis, a treatment that replaces some kidney function if the transplant stops working.